@wanderer_jasnah How does this relate to the finding in e.g. Moderna's phase I that antibody responses were higher after the second dose? I understand that the numbers are averaged across participants but the jump seems too high for just picking up the las
RT @costisifri: To everyone supporting for only 1 dose of a COVID mRNA vaccine 💉 (i.e. increase interval so more ppl can be vaccinated now)…
@sitjarollo @banana_new Resposta à ultima pergunta: sim. A única forma de induzir imunidade de grupo é através de vacinas. A vacina induz resposta imunitária? Sim. Aqui: os links para os estudos de imunogenicidade das vacinas moderna e pfizer https://t.co
RT @costisifri: To everyone supporting for only 1 dose of a COVID mRNA vaccine 💉 (i.e. increase interval so more ppl can be vaccinated now)…
... or this👇 also from https://t.co/HndTOgSL31 https://t.co/uz2JMLJ6Ci
To everyone supporting for only 1 dose of a COVID mRNA vaccine 💉 (i.e. increase interval so more ppl can be vaccinated now), I’m interested in learning more. Maybe start with why I shouldn’t be concerned about this👇from the mRNA-1273 phase 1 study? https:
@Liflower3 @anoticingsenpa1 @latimes Your ignorance is easily refuted https://t.co/esHYX722Ez https://t.co/hhs5Ab8cLe https://t.co/7WeTExGlVY You're welcome.
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @CarlosdelRio7: An mRNA Vaccine against SARS-CoV-2 | Incredibly excited to see the publication in the @NEJM of the @moderna_tx Phase…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
@k_pyrc Tutaj u Matyldy @KludkowskaM 💉 👇🏻
RT @titi40ok: @HaL______ ANMAT no aprobó Sputnik, solo "recomendó", y con eso el min. de Salud la autorizó. En cambió sí aprobó Pfizer. Mo…
RT @titi40ok: @HaL______ ANMAT no aprobó Sputnik, solo "recomendó", y con eso el min. de Salud la autorizó. En cambió sí aprobó Pfizer. Mo…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi chyba najlepsza dotąd rycina pokazująca mechanizm działania szczepionki! Niby prosty, a genialny! https://t.co/qPiWJrqdvX https://t.
@APlatypus5 @cnnbrk Moderna NEJM https://t.co/pDSAIH2b2a
@ClementYChow This is from the Moderna NEJM report: https://t.co/fcPJVCFVDq https://t.co/Qahm9960sL
@AkisAkkep @FinSars @THLorg "Systemic adverse events were more common after the second vaccination, particularly with the highest dose. Three participants (21%) in the 250-μg dose group reported one or more severe adverse events." https://t.co/BcZb4LyeZH
@VACatLady @ScottGottliebMD The first dose provides a significant amount of immunity. The second dose kicks it up a notch. https://t.co/1tqsPZkAtw
RT @Grandm_Anon: Many participants in every Covid-19 vaccine trial have reported adverse reactions including high fever, chills, muscle pai…
@zirkkeli1 An mRNA vaccine against SARS-CoV-2 – preliminary report New England Journal of Medicine, Nov. 12, 2020 https://t.co/BcZb4LyeZH "Adverse events that occurred in more than half the participants included fatigue, chills, headache, myalgia, and pain
RT @Grandm_Anon: Many participants in every Covid-19 vaccine trial have reported adverse reactions including high fever, chills, muscle pai…
@HaL______ ANMAT no aprobó Sputnik, solo "recomendó", y con eso el min. de Salud la autorizó. En cambió sí aprobó Pfizer. Moderna: https://t.co/tiVjiFJujF https://t.co/yn28f53QAV
RT @DocEvenhouse: These are small trials. No long term assessments done. Sure, let's roll it out worldwide cuz COVID. https://t.co/SkXvZ6…
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report. https://t.co/cISou3rW73
@OlivierPeril @ZeClint La plus grande revue médicale au monde https://t.co/3uRtctALfc
@Ryuk_Shngm @Patybooksreader Lo que yo digo es que no tienen ni idea durante cuanto tiempo te hace inmune. Aún están estudiando los casos de voluntarios y tienen previsto el descenso de eficacia de inmunidad durante las próximas semanas-meses. https://t.co
@jeromecharlevo1 @Stalec_ Au contraire, il n'y a rien d'obscure, toutes les données sont disponibles en ligne, y compris les effets indésirables. https://t.co/WqW6daMnvP
@Rouhanif1 از یکی از دوستان خواستم که مقاله برام بفرسته و برام فرستادن و میتونید چکش کنید مقاله واکسن مدرنا تو ژورنال پزشکی نیو انگلند (از معتبرترین ژورنال های پزشکی دنیا) https://t.co/S7kJCNAM76
@alfbru @norabar Tome un paper con info técnica de una vacuna que lo disfrute de NEJM https://t.co/A9qbPcOFJd
Clarification on why the vaccination offers better protection than antibodies from having had Covid-19
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report https://t.co/qXKUROgfqe
@raewynchch Yes for transmission. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report - PubMed https://t.co/s5zfditOel
@RudolphHelmet @nhnebeker Incorrect. Immunization produced a more robust antibody response: “in all dose groups the median magnitude after the second vaccination was in the upper quartile of values in the convalescent serum specimens” https://t.co/0j5yPynj
If you don’t understand at least 95% of this scientific report, don’t argue with me about the COVID and it’s vaccine! https://t.co/2UFCEj9h0V
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
RT @wintergenomics: Ahora hicimos el desglose de los componentes de la vacuna de Moderna, que por ahora sólo tiene la aprobación por parte…
Ahora hicimos el desglose de los componentes de la vacuna de Moderna, que por ahora sólo tiene la aprobación por parte de la FDA. Puedes leer más de la vacuna en: https://t.co/l35ZmraajF https://t.co/jS37W75rqh https://t.co/KblUUdS0zp
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
Any one know how to manage SIRVA? It's happened the last few times I've gotten my flue shot & I'm worried it's gonna be worse with this vaccine. Still gonna go get it when I can I'd just like to be prepared.
Eine Studie mit vielen Nebenwirkungen! An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM https://t.co/fHnW6RpRZy
@biznesmenamator @TimTricity @MZ_GOV_PL @florian_krammer OK -- racja -- czas podsumować co wiadomo nt. szczepionek Pfizera i Moderny (te narazie są dopuszczone, przynajmniej w USA); tu P1/2 dla Pfizera: https://t.co/tY9hKZ4VNB, tu Moderny (P1, ale mają ant
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
@mattjbrunner @iskander This is the Moderna titer trial (published 4 weeks ago at NEJM). They gave various doses (25-250) 4 weeks apart (the 25- 100 mcg is the dose used in their Ph3 trial) https://t.co/KsbKS57z6L One can certainly make the argument for de
@MJGosper @Paul_van_Hoek @BottomleyFiona @apnelson1 @Maximus_004 @Bobby_Network @DingotheDingo1 @lysandergrant @HowardSteen4 @CJBowden1 @ale_battini @UCastellotti @jonrappoport the trial you are referring to was in 45 people. it was a P1 dose-finding safet
@19_usb @Jimbothebull @AlbertoThomas YouTube is not a peer-reviewed source. MRNA vaccines cannot alter your DNA when the RNA is only in the cells for hours to produce antibodies against spike glycoprotein fragments. MRNA does not enter the nucleus or conta
RT @SimoneGezond: @RTLnieuws Dit gaat over het onderzoek naar het covid-vaccin Moderna, inmiddels ook goedgekeurd. Kijk naar de tabel. Bij…
@LeftWingInaros @GovMikeDeWine @US_FDA The FDA released dozens of pages of data for each: https://t.co/s7fJlLdfA6 https://t.co/gDGazxMFAA Pfizer Phase 1: https://t.co/RYx6tMRXho Pfizer Phase 2/3: https://t.co/xTknhNrqxI Moderna Phase 1: https://t.co/viUE
I wanted to highlight Dr. Corbett's achievement, but couldn't decide which of her tweets to re-tweet, until I saw the pretty graph <3 <3 <3
RT @SimoneGezond: @RTLnieuws Dit gaat over het onderzoek naar het covid-vaccin Moderna, inmiddels ook goedgekeurd. Kijk naar de tabel. Bij…
RT @KizzyPhD: The phase 1 preliminary report is out!!! ENJOY THE READ!!! (and the AMAZING immune responses 🙃😊) "An mRNA Vaccine against SA…
@RTLnieuws Dit gaat over het onderzoek naar het covid-vaccin Moderna, inmiddels ook goedgekeurd. Kijk naar de tabel. Bij de hogere doseringen 100% niet kinderachtige bijwerkingen. 2e en 3e groep kregen na hun 2e prik allemaal last van bijwerkingen. https:/
#INFEMECOG Vacuna RNAm contra SARS-CoV-2. Informe preliminar. Resumen: https://t.co/VQMBIMLInt Artículo: https://t.co/uGXPhgb3EI
This is the @Moderna study - 45 participants - Mild/mod side effects: fatigue, chills, headache, myalgia, inj site pain - phase 1, so not an efficacy study, but induced binding & neutralizing antibody responses - 57 d F/U - no EUA, but likely to come
@TalbertSwan @TanteJay An earlier (stage 2) study on Modernas vaccine. https://t.co/PWqGMo3aoD
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
@AntonAntipyev И да, раз уж Вас в PubMed забанили, ловите, для начала, про Pfizer и Moderna, "не имеющих публикаций". https://t.co/iEOtqoqP7N https://t.co/SViGVneHKW
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
@PENELOPPE192 Bien sûr, j'attends votre analyse critique de: https://t.co/gBwPO77FZL
@catherinefonck https://t.co/r7f25pAoNP Résultats de l'étude phase 2, ou 3 dosages différents ont été testés. En conclusion, le choix de la dose 100ug pour la phase 3
RT @CaribeWellness: Me 'graphsplaining' 😅 Adapted from NEJM article (their full original publication accessible at https://t.co/mr1F1RtupO…
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
This paper does provide data supportive of T-cell and IgG response. No IgM data or IgA. This is the Phase I paper of 45 study participants who received the vaccine.
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
RT @NedPagliarulo: More on discussion of binding antibodies' role in building protection, from NIAID scientists who worked on Moderna's vac…
More on discussion of binding antibodies' role in building protection, from NIAID scientists who worked on Moderna's vaccine:
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
RT @KizzyPhD: Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Su…
Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Sure, one needs a boost for robust neutralizing antibodies (panel C), but #bindingantibodiesmatter (day 1 = dose 1, day 29 = dose 2)
RT @CaribeWellness: Me 'graphsplaining' 😅 Adapted from NEJM article (their full original publication accessible at https://t.co/mr1F1RtupO…
RT @CaribeWellness: Me 'graphsplaining' 😅 Adapted from NEJM article (their full original publication accessible at https://t.co/mr1F1RtupO…
RT @CaribeWellness: Me 'graphsplaining' 😅 Adapted from NEJM article (their full original publication accessible at https://t.co/mr1F1RtupO…
RT @CaribeWellness: Me 'graphsplaining' 😅 Adapted from NEJM article (their full original publication accessible at https://t.co/mr1F1RtupO…
RT @tropicalgyndoc: Key take away point (read the article though)
RT @_meganjaay_: this is good.
RT @Lodzermenel: Comparing immune responses of recovered covid patients vs vaccinated people - much more reliable immunity with vaccine.